CCL2 and thyroid cancer: It has been demonstrated that conditional activation of oncogenic BRAF in mouse results in the induction of thyroid cancers with increased CCL2 and CSF1 expression, associated with the recruitment of tumour-associated macrophages (TAMs) [12].